239 related articles for article (PubMed ID: 36085573)
1. Atractylenolide I ameliorates cancer cachexia through inhibiting biogenesis of IL-6 and tumour-derived extracellular vesicles.
Fan M; Gu X; Zhang W; Shen Q; Zhang R; Fang Q; Wang Y; Guo X; Zhang X; Liu X
J Cachexia Sarcopenia Muscle; 2022 Dec; 13(6):2724-2739. PubMed ID: 36085573
[TBL] [Abstract][Full Text] [Related]
2. Lung cancer-derived extracellular vesicles induced myotube atrophy and adipocyte lipolysis via the extracellular IL-6-mediated STAT3 pathway.
Hu W; Ru Z; Zhou Y; Xiao W; Sun R; Zhang S; Gao Y; Li X; Zhang X; Yang H
Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Aug; 1864(8):1091-1102. PubMed ID: 31002945
[TBL] [Abstract][Full Text] [Related]
3. Alantolactone ameliorates cancer cachexia-associated muscle atrophy mainly by inhibiting the STAT3 signaling pathway.
Shen Q; Kuang JX; Miao CX; Zhang WL; Li YW; Zhang XW; Liu X
Phytomedicine; 2022 Jan; 95():153858. PubMed ID: 34861585
[TBL] [Abstract][Full Text] [Related]
4. Carnosol and its analogues attenuate muscle atrophy and fat lipolysis induced by cancer cachexia.
Lu S; Li Y; Shen Q; Zhang W; Gu X; Ma M; Li Y; Zhang L; Liu X; Zhang X
J Cachexia Sarcopenia Muscle; 2021 Jun; 12(3):779-795. PubMed ID: 33951335
[TBL] [Abstract][Full Text] [Related]
5. Exosomal IL-8 derived from Lung Cancer and Colon Cancer cells induced adipocyte atrophy via NF-κB signaling pathway.
Xiong H; Ye J; Xie K; Hu W; Xu N; Yang H
Lipids Health Dis; 2022 Dec; 21(1):147. PubMed ID: 36581870
[TBL] [Abstract][Full Text] [Related]
6. The critical role of STAT3 in biogenesis of tumor-derived exosomes with potency of inducing cancer cachexia in vitro and in vivo.
Fan M; Sun W; Gu X; Lu S; Shen Q; Liu X; Zhang X
Oncogene; 2022 Feb; 41(7):1050-1062. PubMed ID: 35034093
[TBL] [Abstract][Full Text] [Related]
7. Development of a traditional Chinese medicine-based agent for the treatment of cancer cachexia.
Wu KC; Chu PC; Cheng YJ; Li CI; Tian J; Wu HY; Wu SH; Lai YC; Kao HH; Hsu AL; Lin HW; Lin CH
J Cachexia Sarcopenia Muscle; 2022 Aug; 13(4):2073-2087. PubMed ID: 35718751
[TBL] [Abstract][Full Text] [Related]
8. Corylifol A ameliorates muscle atrophy by inhibiting TAOK1/p38-MAPK/FoxO3 pathway in cancer cachexia.
Zhang R; Shen Q; Wang Y; Deng X; Fan J; Gu X; Fan M; Wei K; Cheng CR; Zhang WD; Zhang XW; Liu X
J Cachexia Sarcopenia Muscle; 2023 Oct; 14(5):2098-2113. PubMed ID: 37439183
[TBL] [Abstract][Full Text] [Related]
9. Paeoniflorin alleviated muscle atrophy in cancer cachexia through inhibiting TLR4/NF-κB signaling and activating AKT/mTOR signaling.
Zhu Z; Li C; Gu X; Wang X; Zhang G; Fan M; Zhao Y; Liu X; Zhang X
Toxicol Appl Pharmacol; 2024 Mar; 484():116846. PubMed ID: 38331105
[TBL] [Abstract][Full Text] [Related]
10. A standardized herbal combination of Astragalus membranaceus and Paeonia japonica, protects against muscle atrophy in a C26 colon cancer cachexia mouse model.
Lee SB; Lee JS; Moon SO; Lee HD; Yoon YS; Son CG
J Ethnopharmacol; 2021 Mar; 267():113470. PubMed ID: 33068652
[TBL] [Abstract][Full Text] [Related]
11. Carnosol analogue WK-63 alleviated cancer cachexia by inhibiting NF-κB and activating AKT pathways in muscle while inhibiting NF-κB and AMPK pathways in adipocyte.
Pan X; Zhang G; Wei K; Gu X; Dan J; Zhao Y; Liu X; Cheng C; Zhang X
Toxicol Appl Pharmacol; 2023 Nov; 479():116729. PubMed ID: 37863360
[TBL] [Abstract][Full Text] [Related]
12. A Key Role for Leukemia Inhibitory Factor in C26 Cancer Cachexia.
Seto DN; Kandarian SC; Jackman RW
J Biol Chem; 2015 Aug; 290(32):19976-86. PubMed ID: 26092726
[TBL] [Abstract][Full Text] [Related]
13. Curcumin treatment suppresses cachexia-associated adipose wasting in mice by blocking the cAMP/PKA/CREB signaling pathway.
Wang R; Wei L; Wazir J; Li L; Song S; Lin K; Pu W; Zhao C; Su Z; Zhao Q; Wang H
Phytomedicine; 2023 Jan; 109():154563. PubMed ID: 36610148
[TBL] [Abstract][Full Text] [Related]
14. Carnosol attenuated atrophy of C2C12 myotubes induced by tumour-derived exosomal miR-183-5p through inhibiting Smad3 pathway activation and keeping mitochondrial respiration.
Kuang JX; Shen Q; Zhang RQ; Fang QY; Deng X; Fan M; Cheng CR; Zhang XW; Liu X
Basic Clin Pharmacol Toxicol; 2022 Dec; 131(6):500-513. PubMed ID: 36150451
[TBL] [Abstract][Full Text] [Related]
15. Tumour-derived leukaemia inhibitory factor is a major driver of cancer cachexia and morbidity in C26 tumour-bearing mice.
Kandarian SC; Nosacka RL; Delitto AE; Judge AR; Judge SM; Ganey JD; Moreira JD; Jackman RW
J Cachexia Sarcopenia Muscle; 2018 Dec; 9(6):1109-1120. PubMed ID: 30270531
[TBL] [Abstract][Full Text] [Related]
16. Ameliorating cancer cachexia by inhibiting cancer cell release of Hsp70 and Hsp90 with omeprazole.
Liu Z; Xiong J; Gao S; Zhu MX; Sun K; Li M; Zhang G; Li YP
J Cachexia Sarcopenia Muscle; 2022 Feb; 13(1):636-647. PubMed ID: 34729960
[TBL] [Abstract][Full Text] [Related]
17. Proteomics analysis of C2C12 myotubes treated with atrophy inducing cancer cell-derived factors.
Marzan AL; Chitti SV; Gummadi S; Kang T; Ang CS; Mathivanan S
Proteomics; 2024 Jun; 24(11):e2300020. PubMed ID: 37882347
[TBL] [Abstract][Full Text] [Related]
18. Cryptotanshinone prevents muscle wasting in CT26-induced cancer cachexia through inhibiting STAT3 signaling pathway.
Chen L; Yang Q; Zhang H; Wan L; Xin B; Cao Y; Zhang J; Guo C
J Ethnopharmacol; 2020 Oct; 260():113066. PubMed ID: 32505837
[TBL] [Abstract][Full Text] [Related]
19. Growth of ovarian cancer xenografts causes loss of muscle and bone mass: a new model for the study of cancer cachexia.
Pin F; Barreto R; Kitase Y; Mitra S; Erne CE; Novinger LJ; Zimmers TA; Couch ME; Bonewald LF; Bonetto A
J Cachexia Sarcopenia Muscle; 2018 Aug; 9(4):685-700. PubMed ID: 30009406
[TBL] [Abstract][Full Text] [Related]
20. Fuzheng Xiaoai Decoction 1 ameliorated cancer cachexia-induced muscle atrophy via Akt-mTOR pathway.
Cheng QQ; Mao SL; Yang LN; Chen L; Zhu JZ; Liu X; Hou AJ; Zhang RR
J Ethnopharmacol; 2023 Mar; 303():115944. PubMed ID: 36410574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
